Evidence that Tamoxifen Preserves Bone Density in Late Postmenopausal Women with Breast Cancer

Author： Resch Alexandra Biber Eva Seifert Michael Resch Heinrich

ISSN： 0284-186X

Source： Acta Oncologica, Vol.37, Iss.7-8, 1998-12, pp. : 661-664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer

By Zidan Jamal Keidar Zohar Basher Walid Israel Ora

Medical Oncology, Vol. 21, Iss. 2, 2004-06 ,pp. : 117-121

Humana Press, Inc

Access to resources Recommend Favorite

Bone mineral density and risk of postmenopausal breast cancer

By Grenier Debjani

Breast Cancer Research and Treatment, Vol. 126, Iss. 3, 2011-04 ,pp. : 679-686

Springer Publishing Company

Access to resources Recommend Favorite

Treatment Options For Postmenopausal Women with Tamoxifen-Resistant Advanced Breast Cancer

By Cheung K-L. Robertson J.F.R.

American Journal of Cancer, Vol. 1, Iss. 4, 2002-01 ,pp. : 293-300

Adis International

Access to resources Recommend Favorite

Bone Mineral Density and Endogenous Hormones and Risk of Breast Cancer in Postmenopausal Women (United States)

By Buist D.S.M.

Cancer Causes and Control, Vol. 12, Iss. 3, 2001-04 ,pp. : 213-222

Springer Publishing Company

Access to resources Recommend Favorite

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 135-136

Informa Healthcare

Access to resources Recommend Favorite